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http:WHAT THIS PAPER ADDS
The patency of the grafts to renal and visceral arteries is the most important aspect during a visceral hybrid
procedure. In this study we report for the ﬁrst time that the long-term patency of the grafts is excellent except
for the right renal artery. This technique should be preferred for exclusion of thoraco-abdominal aortic aneu-
rysms in emergency cases. The technical difﬁculties with the graft to the right renal artery could be avoided by
careful anastomosis or by choosing an alternative technique.Objectives: This article aims to report for the ﬁrst time the long-term bypass graft patency after visceral hybrid
repair of thoraco-abdominal aortic aneurysms (TAAAs).
Patients and methods: Between July 2004 and September 2012 the visceral hybrid procedure was performed in
46 patients with TAAAs, who did not qualify for an open or total endovascular repair. The inﬂow sites of visceral
revascularisation originated either from the native artery or from aortic prosthetic grafts. All patients were
included in the study and were followed up with subsequent computed tomography (CT) (mean follow-up 23.5
months).
Results: In 46 patients (67.5 years in median; range 35e88), 164 grafts were performed. The 30-day primary
patency of all grafts was 87.9%. The long-term patency remained 87.9  2.7%, 86.1 3.2% and 86.1  3.2% after
1, 3 and 5 years, respectively. The patency of all hepatic grafts was 100%. The patency of grafts to the superior
mesenteric artery was 88.8  4.8% after 1, 3 and 5 years. The patency was 87.2  6%, 87.2  6% and 87.2  6%
for the left renal artery and 76  7%, 69.6  8.8% and 69.6  8.8% for the right renal artery after 1, 3 and
5 years, respectively.
Conclusions: Hybrid repair demonstrates excellent results regarding long-term bypass graft patency of
renovisceral arteries except for the right renal artery.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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associated with high mortality and morbidity rates. The
rupture rate of non-surgically treated patients sets to be
about 23%1 with overall surgical mortality rate of about
53%.2 On the other hand, perioperative mortality of non-
ruptured TAAA is reported between 4% and 22%3e6 with
overall 30-day mortality of 5e19% and 1-year mortality of
around 31%,7 demonstrating an overall national data of
mortality rate approaching 20%.8 The risk of neurologic
deﬁcits (paraparesis or paraplegia) ranges from 2.7% to
13.2% and that of acute renal failure with the need for
dialysis is around 5%.7,9e13
One technique for exclusion of TAAA is the hybrid proce-
dure, combining the endovascular technique with debranch-
ing of the visceral (coeliac and mesenteric) and/or renalresponding author. Tel.:þ49 221 47832403; fax: þ49 221 47832499.
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//dx.doi.org/10.1016/j.ejvs.2013.03.012arteries fromthe aorta or common iliac artery (CIA).This allows
the landing zone for the stent graft to be in the abdominal
aorta. The perioperative mortality rates after the visceral
hybrid technique in patientswith TAAA range between0%and
44%14e19 with the mean mortality rate of 12.8%.20 In two
larger studies withmore than 50 patients the 30-daymortality
rate was 14.9% and 8.6%, respectively.21,22 The technique
being still major surgery, perioperative 30-day morbidity, such
as spinal cord ischaemia (SCI), renal insufﬁciency and mesen-
teric ischaemia, is reported to be around 9%, 15% and 8%,
respectively.15,18,21e25
Regarding the visceral/renal graft patency the current
available data indicate short-term patency rates of about
95%.15,21e27 However, there are no published data on the
long-term graft patency of the revascularised visceral/renal
vessels.
The aim of the present study was to deﬁne the long-term
bypass graft patency after revascularisation of renovisceral
arteries during hybrid repair of TAAA during a mean follow-
up period of 23.5 months (range 0.7e101.5 months).
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Between July 2004 and September 2012 the visceral hybrid
procedure was performed in patients with TAAAs, who did
not qualify for an open or total endovascular repair. Based on
the individual situation, such as the emergency status,
anatomical conditions or multiple co-morbidities, the open or
endovascular techniques were rejected. During the same
study period, 27 total endovascular procedures using fenes-
trated/branched stent grafts (7 with TAAA) were performed
and 15 patients underwent the open procedure. The patient
cohort consisted of 46 patients (28 males and 18 females
with a median age of 67.5 years (35e88)) with TAAA (aneu-
rysm diameter 72.5 mm in median; range 60e110 mm).
The median preoperative serum creatinine level was
101.66 mmol l1 (44.2e548.1 mmol l1). The median preop-
erative haemoglobin level was 11.8 g dl1 (5e16.7 g dl1).
Preoperative imaging procedures contained contrast-
enhanced computed tomography (CTA) and intra-arterial
digital subtraction angiography (DSA) in selected patients
as described before.19 TAAAs were classiﬁed according to
the modiﬁed CrawfordeSaﬁ classiﬁcation (type I e n ¼ 9,
type II e n ¼ 17, type III e n ¼ 8, type IV e n ¼ 1, type
V e n ¼ 10). One patient had a paravisceral aortic aneu-
rysm (pAAA). Ten patients had a case of an aortic dissection
with consecutive aneurysm: two with acute and eight with
chronic dissections. A total of 18 patients were symptom-
atic with either thoracic (9) or abdominal (9) pain. Twelve
symptomatic patients and one asymptomatic patient had
a contained rupture. Twelve symptomatic patients, of
whom 11 had a rupture, underwent emergent visceral
hybrid operation. One symptomatic patient with acute
aortic dissection showed neurological deﬁcits in terms of
paraplegia due to abdominal aortic occlusion. Fourteen
symptomatic patients and one asymptomatic patient had
pleural effusion. One patient had an aorto-oesophageal
ﬁstula.
A total of 31 patients underwent simultaneous repair and
15 patients underwent staged repair. One patient died
between the two stages due to an occlusion of the graft to
the superior mesenteric artery (SMA) and a consecutive
bowel ischaemia. The median time period between the two
stages was 9 days (1e55 days). Cerebrospinal ﬂuid drainage
was attained in 32 patients based on patients’ individual
characteristics, such as spinal column anatomy or anti-
coagulation taken, as well as surgeon’s preference. The
overall data and characteristics are presented in Table 1.
The proximal landing zone of the endografts was in 16
patients in Zone 4, in 15 patients in Zone 3 and in 13
patients in Zone 2 (Criado’s anatomical landing zone map28).
In six patients we performed a left carotid-to-subclavian
bypass to preserve the perfusion of the left subclavian
artery (LSA) and thereby reduce the probability of mainly
cerebellum ischaemia and SCI. In seven cases at the
beginning of the study the LSA was not preserved, as the
importance of its preservation was not appreciated at that
time. One patient had a proximal landing zone in Zone 1. In
this case a carotid-to-carotid bypass graft was performed.All patients were preoperatively classiﬁed according to
the American Society of Anesthesiologists (ASA) classiﬁca-
tion29 and underwent risk evaluation according to European
System for Cardiac Operative Risk Evaluation (EuroSCORE)
guidelines.30
Individual risk factors and co-morbidities of patients
involved arterial hypertension, history of myocardial
infarction, coronary heart disease (current angina and/or
history of previous coronary interventions such as angio-
plasty or coronary artery bypass graft), chronic obstructive
pulmonary disease, peripheral arterial disease (history of
previous interventions such as angioplasty or bypass
surgery, current Fontaine stages IeIV and/or reduction of
ankleebrachial index <0.8), diabetes mellitus, heart insuf-
ﬁciency (limitations of activity according to New York Heart
Association (NYHA) functional classiﬁcation and/or reduc-
tion of ejection fraction <30%) and renal insufﬁciency
(current creatinine level >141 mmol l1 with or without
need of dialysis). A total of 29 patients (63%) were identi-
ﬁed to be either active or past smokers. As many as 28
patients (61%) had undergone previous cardiovascular
operations; 16 of those had had either open or endovas-
cular abdominal aortic aneurysm repair (of those 4 with
type I, 4 with type II, 4 with type III, 1 with type IV and 2
with type V TAAA extend and the patient with pAAA) and 10
patents had had thoracic aortic aneurysm repair (of those 6
with type II and 2 with type III and V TAAA extend each).
The ﬁnal patient with a type V aneurysm had both thoracic
and abdominal aortic aneurysms repaired (Table 2).
The supplementary preoperative diagnostics were per-
formed by means of echocardiography, lung function or
coronary angiogram when time allowed it.
All procedures were performed by two vascular surgeons
(M.G. and/or J.B.), each with an individual expertise of
more than 20 years. The two parts were performed either
simultaneously or staged depending on the aneurysm
status, intra-operative blood loss and haemodynamic
stability. The reason for a renovisceral bypass was based on
the extent of the aneurysm as well as the functionality/
existence of the vascularised organ (end-stage renal disease
or failing kidney). The debranching was performed in all
cases through a trans-peritoneal approach using 8-mm
Dacron grafts for the hepatic and SMA and 7- or 6-mm
Dacron grafts for the renal arteries. The suturing of the
grafts was performed with 5/0 or 6/0 polypropylene. In no
case was any adjunctive procedure necessary.
Follow-up
The postoperative follow-up was assessed by means of CTA
before the patient was discharged and then at 3, 6 and 12
months and annually thereafter. In the case of chronic renal
insufﬁciency and suitable examination conditions duplex
ultrasound was used for bypass patency in order to mini-
mise the amount of contrast medium applied. No patients
were lost during the follow-up.
The primary ‘end’ point of the study was occlusion of at
least one graft. The secondary ‘end’ point was death.
Table 1. Perioperative characteristics of TAAA and its implications.
Pat. TAAA extent Dissection Symptomatic Rupture Pleural effusion Operation status Procedure CSF-D
1 Type II No Yes Contained Yes Emergent Staged No
2 Type III No Yes Contained No Emergent Simultaneous No
3 Type I Chronic Yes No Yes Elective Simultaneous No
4 Type II No No No No Elective Simultaneous No
5 Type V Chronic No No No Elective Simultaneous No
6 Type II No No No No Elective Simultaneous No
7 Type II Acute Yes Contained Yes Emergent Simultaneous No
8 Type III No Yes Contained No Emergent Staged No
9 Type III No No No No Elective Simultaneous No
10 Type V No No No No Elective Simultaneous Yes
11 Type II Acute Yes No Yes Emergent Simultaneous Yes
12 Type I Chronic No No No Elective Staged Yes
13 Type II Chronic No No No Elective Staged Yes
14 Type V No No No No Elective Abandoned Yes
15 Type III No No No No Elective Staged Yes
16 Type II No Yes Contained Yes Emergent Simultaneous Yes
17 Type III No No No No Elective Simultaneous Yes
18 Type I No No No No Elective Simultaneous Yes
19 Type III No No No No Elective Staged No
20 Type II No Yes Contained Yes Emergent Simultaneous Yes
21 Type II Chronic Yes No No Elective Simultaneous Yes
22 Type II Chronic Yes Contained Yes Emergent Simultaneous Yes
23 Type V No Yes Contained Yes Elective Simultaneous Yes
24 Type I Chronic No No No Elective Simultaneous Yes
25 Type IV No No No No Elective Simultaneous Yes
26 Type V No No No No Elective Simultaneous Yes
27 Type II No No No No Elective Staged Yes
28 Type I No No No Yes Elective Staged Yes
29 Type V No No No No Elective Simultaneous Yes
30 Type II No No Contained No Elective Staged No
31 Type III No No No No Elective Staged No
32 Type II No Yes Contained Yes Emergent Simultaneous No
33 Type V No No No No Elective Staged Yes
34 Type V No No No No Elective Simultaneous No
35 Type III No No No No Elective Simultaneous Yes
36 Type II No No No No Elective Simultaneous Yes
37 Type V No Yes Contained Yes Emergent Simultaneous Yes
38 Type V No No No No Elective Simultaneous Yes
39 Type I No Yes No Yes Elective Simultaneous Yes
40 Type II Chronic Yes No No Elective Staged Yes
41 Type II No Yes Contained Yes Emergent Simultaneous Yes
42 Type I No Yes Contained Yes Emergent Simultaneous Yes
43 pAAA No No No No Elective Simultaneous Yes
44 Type II No No No No Elective Staged Yes
45 Type I No No No No Elective Staged Yes
46 Type I No Yes No Yes Elective Simultaneous Yes
TAAA: thoracoabdominal aortic aneurysm, CSF-D: cerebro-spinal ﬂuid drainage, pAAA: paravisceral abdominal aortic aneurysm.
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Statistical analyses were performed using Statistical Package
for the Social Sciences (SPSS) Statistics Software (IBM,
Armonk, NY, USA). The patency rates were assessed using
the KaplaneMeier analysis and were described for the
grafts performed.RESULTS
The outcome of 46 patients was retrospectively analysed
from a prospectively managed database. The inﬂow sitesoriginated from the native CIA (14), the distal aorta (16) or an
aortic prosthetic graft (7 bifurcated grafts, 4 aortic tubes and
5 iliac-femoral graft). In total, four-vessel debranching was
performed in 31 patients, three-vessel debranching was
performed in 11 patients and two-vessel debranching was
performed in 3 patients. One patient underwent a one-vessel
debranching of SMA due to chronic occlusion of the coeliac
trunk. The grafts used are summarised in Table 3.
The median postoperative in-hospital stay was 23.5 days
(2e101) with a median postoperative stay at the intensive
care unit for 7 days (1e100).
Table 2. Patients’ preoperative risk factors and comorbidities.
Patients’ comorbidities Number of
patients
Percentage
of patients (%)
Hypertension 43 93
Previous MI 5 10
CHD 12 26
Heart insufﬁciency 5 11
COPD 16 35
PAD 14 30
Smoking (current or past) 29 63
Diabetes 3 6
Renal insufﬁciency 16 35
Dialysis 8 17
ASA classiﬁcation ASA I 0 0
ASA II 2 4
ASA III 22 48
ASA IV 20 44
ASA V 2 4
EuroSCORE 11 11 24
Previous
surgery of
Abdominal aorta 16 35
Thoracic aorta 10 22
Both 1 2
Cardiac 3 7
Others 7 15
MI: myocardial infarction, CHD: coronary heart disease, COPD:
chronic obstructive pulmonary disease, PAD: peripheral arterial
disease, ASA: American Society of Anesthesiologists, EuroSCORE:
European System for Cardiac Operative Risk Evaluation.
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All procedures, except for the patient who died between two
stages, were completed successfully, with no completion
angiographic endoleaks detected. There was no perforation,
dissection or peripheral embolisation during the operation.
Thirty-day mortality
The patient cohort that did not survive the ﬁrst 30 days
consisted of 14 multimorbid patients (4 males and 10
females). Seven patients had a ruptured TAAA, one with
an aorto-oesophageal ﬁstula. Five patients died due to
graft occlusion after thrombectomy (TE) (three patients
with intestinal ischaemia and one patient with gastric/
hepatic ischaemia had thrombotic occlusion of the grafts
to the SMA: two of them had also an occlusion of the
grafts to the RRA); the ﬁfth patient had an occlusion of
both renal grafts and died after TE due to a multi-organ
failure.
Morbidity
The major 30-day postoperative complications included SCI
with four cases of immediate and one case of delayed
paraplegia, gastro-intestinal/hepatic ischaemia, renal insuf-
ﬁciency with the needs of dialysis, cerebral neurological
deﬁcits, prolonged ventilation alongside with tracheotomy
and pneumonia (Table 4).
The postoperative CTA revealed 13 endoleaks (9 of
which were within the 30-day period): 4 type Ia, 2 type Ib, 6
type II and 1 type III. Five of those underwentsupplementary procedures. One type-Ib endoleak was
corrected on the third postoperative day by deploying a left
aorto-iliac endograft. The patient also underwent simulta-
neous TE of the left leg of the pre-existing aortobifemoral
bypass due to its occlusion. Furthermore, 1 week later an
occlusion of the right renal graft was detected, which was
not revised due to the patient’s reduced general condition
and difﬁculty to access after many previous surgeries. The
patient suffered from an SCI with paraplegia and was dis-
charged on 76th postoperative day without need for dial-
ysis. Subsequently, he died 5 months later. The second
patient with type-Ib endoleak underwent successful
deployment of an additional stent graft 10 months later
due to the progression of the endoleak. One type-II
endoleak was corrected via coil embolisation of the
coeliac trunk 10 months later due to progressing size of
aneurysm. The patient had also an early asymptomatic
occlusion of the SMA, which was not revised. Another type-
II endoleak was also corrected through coil embolisation of
the left gastric artery 26 months later by interventional
radiologists. During the follow-up at 2.5 and 6 years,
respectively, there was a cranial dislocation of the proximal
aortic stent graft in two patients and beginning consecutive
type-Ia endoleak in one of them. Both patients were then
successfully treated by an endovascular chimney-graft
technique of the aortic arch.
The other endoleaks were not corrected. One patient
with type-II endoleak showed regression of endoleak and
aneurysm size and the other one died 6 months later. The
rest died early after detection. The 30-day postoperative
complications of each patient are demonstrated in Table 5.
Long-term results
The all-cause survival rate was 45.5  7.4% at 1 year,
38  7.3% at 3 years and 34.9  7.4% at 5 years (Fig. 1). Six
patients died early after discharge to a rehabilitation centre
due to long-term mechanical ventilation and tracheostomy.
One patient died 4 years later due to a mycotic aneurysm of
the SMA and prosthetic infection with secondary aorto-
duodenal ﬁstula. Another patient had a complicated lethal
Stanford-A aortic dissection 2 months after the primary
procedure. The rest of patients died of non-procedure
related reasons. No late cases of bowel ischaemia were
reported during the follow-up.
The patency of supra-aortic arteries was 100% (except for
the intentionally covered LSA).
Bypass-graft patency
There were altogether 38 grafts to the hepatic artery, 46
grafts to the SMA, 39 grafts to the left (LRA) and 41 grafts to
the right renal artery (RRA). The 30-day overall primary
patency of the grafts was 87.9  2.7%. The CT scan
demonstrated occlusion of SMA bypass in ﬁve cases, of the
left renal in four and of the right renal bypass in nine cases.
Seven of those (three to SMA, one to LRA and three to RRA)
were corrected surgically through TE. No surgical reasons
for graft occlusion were identiﬁed. The rest were
Table 3. Characteristics of the grafts.
Patient No. Inﬂow source No. of grafts Visceral debranching Stent-grafts
1 Aorta 3 SMA, renal arteries Gore Excluder
2 Aorta 3 SMA, renal arteries Gore Excluder
3 Aorta 3 SMA, renal arteries Cook Zenith, Gore Excluder
4 Iliac 3 SMA, renal arteries Gore Excluder
5 Aorta 4 Hepatic artery, SMA, renal arteries Gore Excluder
6 Aorta 4 Hepatic artery, SMA, renal arteries Gore Excluder
7 Aorta 4 Hepatic artery, SMA, renal arteries Gore Excluder
8 Iliac 3 Hepatic artery, SMA, LRA Gore Excluder
9 Iliac 4 Hepatic artery, SMA, renal arteries Gore Excluder
10 Iliac 4 Hepatic artery, SMA, renal arteries Gore Excluder
11 Iliac 2 Hepatic artery, SMA Gore Excluder
12 Iliac 4 Hepatic artery, SMA, renal arteries Gore Excluder
13 Prosthesis 4 Hepatic artery, SMA, renal arteries Gore Excluder
14 Prosthesis 4 Hepatic artery, SMA, renal arteries
15 Aorta 4 Hepatic artery, SMA, renal arteries Gore Excluder
16 Prosthesis 4 Hepatic artery, SMA, renal arteries Gore Excluder
17 Prosthesis 4 Hepatic artery, SMA, renal arteries Gore Excluder
18 Aorta 2 Hepatic artery, SMA Cook Zenith
19 Aorta 4 Hepatic artery, SMA, renal arteries Gore Excluder
20 Aorta 4 Hepatic artery, SMA, renal arteries Cook Zenith, Gore Excluder
21 Prosthesis 3 SMA, renal arteries Gore Excluder
22 Prosthesis 4 Hepatic artery, SMA, renal arteries Gore Excluder
23 Iliac 3 SMA, renal arteries Cook Zenith
24 Iliac 4 Hepatic artery, SMA, renal arteries Gore Excluder
25 Prosthesis 4 Hepatic artery, SMA, renal arteries Gore Excluder
26 Aorta 3 Hepatic artery, SMA, RRA Gore Excluder
27 Prosthesis 3 Hepatic artery, SMA, RRA Gore Excluder
28 Iliac 3 Hepatic Artery, SMA, RRA Gore Excluder
29 Iliac 4 Hepatic artery, SMA, renal arteries Gore Excluder
30 Prosthesis 4 Hepatic artery, SMA, renal arteries Gore Excluder
31 Prosthesis 4 Hepatic artery, SMA, renal arteries Gore Excluder
32 Prosthesis 4 Hepatic artery, SMA, renal arteries Gore Excluder
33 Aorta 4 Hepatic artery, SMA, renal arteries Gore Excluder
34 Aorta 4 Hepatic artery, SMA, renal arteries Gore Excluder
35 Prosthesis 4 Hepatic artery, SMA, renal arteries Gore Excluder
36 Iliac 4 Hepatic artery, SMA, renal Arteries Gore Excluder
37 Prosthesis 4 Hepatic artery, SMA, renal arteries Gore Excluder
38 Iliac 3 SMA, renal arteries Gore Excluder
39 Aorta 1 SMA Cook Zenith, Gore Excluder
40 Prosthesis 4 Hepatic artery, SMA, renal arteries Gore Excluder
41 Iliac 4 Hepatic artery, SMA, renal arteries Gore Excluder
42 Prosthesis 4 Hepatic artery, SMA, renal arteries Gore Excluder
43 Iliac 2 Hepatic artery, SMA Gore Excluder
44 Aorta 4 Hepatic artery, SMA, renal arteries Gore Excluder
45 Prosthesis 4 Hepatic artery, SMA, renal arteries Gore Excluder
46 Aorta 4 Hepatic artery, SMA, renal arteries Gore Excluder
LRA: left renal artery, RRA: right renal artery, SMA: superior mesenteric artery , Gore: W.L. Gore & Associates, Flagstaff, Arizona, USA ,
Cook: Cook Incorporated, Bloomington, Indiana, USA.
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one patient had a stenosis of left renal bypass corrected by
placing a new anastomosis to prevent future occlusion.
During the follow-up there was another and ﬁnal case of
occlusion of the right renal graft after 2.3 years.
The inﬂow sources for the occluded RRA grafts were in
ﬁve cases the infrarenal aorta, in one case the right CIA and
in three cases prosthesis (one iliac-femoral and two bifur-
cated grafts).
The primary patency of all grafts was after 1 year
87.9  2.7% and after 3 and 5 yearse86.1  3.2% (Fig. 2).The secondary patency rates of all grafts were 100%. All
hepatic grafts were patent. Patency of grafts was for the
SMA 88.8  4.8%, 88.8  4.8% and 88.8  4.8%; for the
LRA 87.2  6%, 87.2  6% and 87.2  6% and for the RRA
76  7%, 69.6  8.8% and 69.6  8.8% after 1, 3 and 5
years, respectively (Fig. 3).DISCUSSION
The surgical treatment of the TAAA carries high mortality
and morbidity rates despite various available surgical
Table 5. Major postoperative 30-days complications of each
patient individually.
Patient No. Major postoperative 30-days complications
1 Graft occlusion (RRA)
2 None
3 None
4 None
5 Tracheostomy
6 Graft occlusion (RRA)
7 SCI, cerebral neurological deﬁcits, tracheostomy,
dialysis
8 Pneumonia, tracheostomy, dialysis, pancreatic
ischemia
9 SCI, pneumonia, tracheostomy, dialysis
10 Graft occlusion (SMA), Type-II endoleak
11 None
12 None
13 Pneumonia
14 Graft occlusion (SMA), bowel ischemia
15 None
16 Graft occlusion (LRA), Type-III endoleak,
pneumonia, tracheostomy, dialysis
17 Graft occlusion (RRA), type-Ib endoleak, SCI,
pneumonia, tracheostomy, dialysis
18 None
19 Graft occlusion (RRA), pneumonia, tracheostomy,
dialysis, cerebral neurological deﬁcits
20 Type-Ia endoleak
21 None
22 Type II endoleak, bowel ischemia
23 Myocardial infarction, gastric ischemia
24 Graft occlusion (LRA), SCI
25 Graft occlusion (RRA and SMA), bowel ischemia
26 None
27 Pneumonia, tracheostomy
28 Graft occlusion (RRA)
29 None
30 Pneumonia, tracheostomy, Type-Ia endoleak
31 Graft occlusion (RRA and LRA), Type-Ia endoleak,
pneumonia, tracheostomy, gastric ischemia,
dialysis
32 None
33 None
34 Type-II endoleak
35 SCI
36 Bowel ischemia
37 Graft occlusion (LRA)
38 Graft occlusion (SMA), gastric/hepatic ischemia,
dialysis
39 None
40 Type-Ib endoleak
41 Type-II endoleak, esophageal perforation
42 Type-II endoleak, cerebral neurological deﬁcits,
tracheostomy
43 None
44 None
45 Graft occlusion (RRA), cerebral neurological
deﬁcits, pneumonia, tracheostomy
46 Graft occlusion (RRA and SMA), bowel ischemia
SCI: spinal cord ischemia, LRA: left renal artery, RRA: right renal
artery, SMA: superior mesenteric artery.
Table 4. Major postoperative 30-days complications.
Complication No. of
patients
Percentage (%)
Tracheostomy 12 26
Pneumonia 10 22
Dialysis 8 17
SCI with paraplegia 5 10
Cerebral neurological deﬁcits 4 9
Gastro-intestinal ischemia 10 22
Gastro-intestinal ischemia
due to graft occlusion
4 9
Myocardial infarction 1 2
Peripheral embolization 0 0
SCI: spinal cord ischemia.
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procedure has lower mortality and morbidity rates
comparing to open repair.21,22
The endovascular technique using branched/fenestrated
endografts is rapidly developing. In 2010, Verhoeven and
co-workers presented their 8-year experience in 100
patients treated with the fenestrated stent grafts for short-
necked and juxtarenal AAA with 94% technical success.31
They demonstrated estimated survival rates of 90.3%,
84.4% and 58.5% at 1, 2 and 5 years, respectively. The long-
time visceral branch patency was 93.3% at 5 years with
stent occlusions occurring during the ﬁrst 2 postoperative
years. The main concern of the study was late renal event
with a signiﬁcant deterioration of renal function in 25%.
Recently, Austermann and co-workers reported follow-up
after 12.9 months in 107 patients after endovascular
fenestrated/branched repair of pAAA and TAAA. They
described complications in 28 patients (26%) who subse-
quently underwent 34 secondary procedures. There were 6
limb-graft stenosis/thromboses, 8 in-stent visceral vessel
stenosis/occlusions, 8 migrations/endoleaks type-I with or
without visceral stent fractures and 12 type-III endoleaks.32
Thus in light of this, the hybrid procedure favours well,
especially as we had very few type-I and type-III endoleaks
and even fewer limb occlusions. Further, since branched/
fenestrated endografts have a long producing time, the
hybrid approach may be used for emergent surgeries of
TAAA. After ﬁnishing this manuscript the ﬁrst off-the-shelf
Zenith t-Branch Thoracoabdominal Endovascular Graft
(Cook Incorporated, Bloomington, IN, USA) is available in
Europe where the results are eagerly awaited.
The present study demonstrates for the ﬁrst time long-
term bypass patency in these patients. Nowadays
a bypass to the renal arteries and visceral arteries is less
commonly performed as most of these arteries are being
treated with endovascular techniques especially when
dealing with stenotic lesions. Looking at the old data on
patency of renal bypasses, one ﬁnds primary patency rates
of 87%, 79% and 79% at 1, 3 and 5 years of follow-up, as in
the study of Weaver and colleagues after renal revascular-
isation of patients with Takayasu arteritis-induced renal
artery stenosis.33 Another similar article reported primary
patency rates of 92%, 89% and 79% at 1, 3 and 5 years of
Figure 3. Long-term patency of grafts to coeliac trunk/hepatic,
superior mesenteric, left and right renal arteries in months.
Figure 1. All-cause survival rate in months.
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combination with AAA or TAAA surgery, are less well
described.
The application of the chimney technique to preserve
visceral and/or renal arteries represents an alternative in
emergency cases. In relatively larger studies the patency rates
of chimney grafts were reported to range between 93% and
97%.35e37 However, the chimney technique has its limitations
with short postoperative follow-up results available.
We had the most occluded grafts to the RRA. Interest-
ingly, most occlusions appeared within the 30-day period
after the surgery. The frequent short-term occlusion of the
right renal graft could be associated with anatomical courseFigure 2. Long-term patency of all renovisceral grafts in months.and technical difﬁculties of anastomosis. This technical
problem might be avoided by applying the Kocher
manoeuvre or using the Viabahn open rebranching tech-
nique (VORTEC) technique.38
We detected only one late occlusion of a renal bypass
graft after 2.3 years, which, based on the CT imaging,
appeared due to a kinking of the graft near the anasto-
mosis. Encouragingly, we did not reveal any occlusion of the
hepatic/truncal graft.
All our patients underwent retrograde revascularisation
of visceral/renal arteries. Although, antegrade revascular-
isation from the distal descending aorta appears more
physiological, it is still associated with a thoracotomy.
Kabbani and co-workers compared antegrade versus retro-
grade revascularisation and reported worse results in the
group that underwent antegrade revascularisation. This was
most probably due to higher intra-operative blood loss and
longer operative time.26 On the other hand, Markatis and
colleagues published recently a retrospective analysis of
a small series that underwent an antegrade visceral artery
debranching during hybrid repair with low mortality and
good patency rates.39
CONCLUSIONS
As the total endovascular repair for TAAA using side-
branched/fenestrated grafts is costly and not available ‘on
the shelf’ due to long producing time, the hybrid repair
presents a promising alternative, especially in emergency
cases. The results of the ﬁrst off-the-shelf thoracoabdominal
endovascular graft still remain to be evaluated. Although
the hybrid repair of TAAA is associated with mortality and
morbidity rates, it is feasible during emergent aneurysm
repair. Moreover, it demonstrates excellent results
regarding long-term bypass graft patency of renovisceral
arteries except for the RRA.
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